featured
Association of RAD51 With Homologous Recombination Deficiency and Outcomes in Untreated TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of RAD51 with Homologous Recombination Deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial
Ann. Oncol 2021 Sep 11;[EPub Ahead of Print], A Llop-Guevara, S Loibl, G Villacampa, V Vladimirova, A Schneeweiss, T Karn, DM Zahm, A Herencia-Ropero, P Jank, M van Mackelenbergh, PA Fasching, F Marmé, E Stickeler, C Schem, R Dienstmann, S Florian, V Nekljudova, J Balmaña, E Hahnen, C Denkert, V SerraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.